BIOVIA リソースセンター

本資料は、完全なデジタル変革を進めにあたりチェックリスト形式でまとめた手順書になっています。デジタルで統合されたラボの基盤づくりをご紹介します

EBooks

他社製品よりもリーズナブルな導入・維持コストでご案内します

Datasheets

お客様事例や動画、ホワイトペーパー、ウェビナーなど最新情報をチェック

Community News

コンサルティングサービスとクラウド版電子実験ノートを導入。世界初の商品生み出す研究所さらなるイノベーション目指す

White Papers

BIOVIA 2026年アップデート情報をお届けします 各製品ごとに詳しく解説します

Technical Documentation

BIOVIA Live

EBooks

BIOVIA Live

Technical Documentation

BIOVIA Live

Technical Documentation

BIOVIA Live

Technical Documentation

e ブック

BIOVIA は、AI を活用した3DEXPERIENCE プラットフォームで研究開発を統合します。2,000 人以上の製薬、消費材、材料科学のトップ・リーダーから信頼されています。

Contact

e ブック

Discover how Marmion Academy’s high school research program gives students hands-on engineering experience with 3DEXPERIENCE simulation tools.

Customer Story

The Korean Chemical manufacturer integrates product lifecycle management with an electronic lab notebook to standardize experimental data and establish a foundation for AI-driven formulation and materials research in the future.

Customer Story

Aboca blends science and nature to create natural product healthcare solutions, using BIOVIA ONE Lab to boost efficiency, compliance, and innovation.

Customer Story

Located in Israel’s Galilee region, MIGAL is an applied research institute, specializing in biotechnology and computational sciences, plant science, precision agriculture and environmental sciences, as well as food, nutrition and health.

Customer Story

How BIOVIA’s scientific virtual companion, accelerated by NVIDIA, helps scientists move from question to answer by orchestrating the right data, models and scientific workflows.

Article

BIOVIA’s agentic AI for drug discovery on the 3DEXPERIENCE platform is getting an upgrade. By building the MARIE virtual companion with the NVIDIA BioNeMo Agent Toolkit and BioNeMo, we are shortening the path from a scientist’s question to a correctly executed computation while improving the accuracy, precision, explainability, and traceability that real R&D decisions depend on.

Article

BIOVIA Helmsman Brings Agentic AI to the Backbone of Modern Therapeutics

Article

Modern make-on-demand combinatorial spaces now span trillions of drug-like molecules, providing unprecedented chemical diversity but making selection increasingly complex. BIOVIA Generative Therapeutics Design helps navigate this space by evolving molecules toward project goals while ensuring they remain practical to synthesize and order.

Article

BIOVIA Generative Therapeutics Design integrates NVIDIA MolMIM NIM, combining generative AI with classical simulation to design better drugs faster, in a unified workflow.

Article

How the Dassault Systems—NVIDIA collaboration is accelerating drug and materials discovery

Article

BIOVIA’s Continued Collaboration with UC Berkeley’s MSSE Program

Article

AI transforms R&D only when data is connected, consistent, and scientifically meaningful.

Article

For a New Era of Regulatory Compliance

Article

Mitigate the risk of AI errors and chart a path forward with new initiatives.

Article

What biologists really want—from early discovery to biomanufacturing.

Article

How Real-Time Analytics Enables Faster Pharmaceutical Release

Article